BAX Baxter International
NYSE · SEC CIK 10456 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 218 since 2021-08-04, latest 2026-09-03 16:19
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Teaff James | Pres, CCS | — | — |
| Foster Julie | Pres, Front Line Care | — | — |
| Soriano Maria Cecilia | Group Pres, ITT, Pharma | — | — |
| Carlisle Cynthia | EVP, CHRO | — | — |
| Ampofo William A. II | Dir | — | — |
| Rasul Reazur | EVP, Group Pres, Healthcare | — | — |
| Hider Andrew P. | Pres, CEO, Dir | — | — |
| Rosenbloom David S. | EVP, GC | — | — |
| Wilkes David S. | Dir | — | — |
| Wallace Steven P. | Pres, Adv. Surgery | — | — |
Transactions 266
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-03 16:19 | 2026-09-01 | BAX | Teaff James | Pres, CCS | F - Tax | $25.48 | -750 | 30.4K | -2% | -$19.1K | |
| 2026-09-03 16:18 | 2026-09-02 | BAX | Hider Andrew P. | Pres, CEO, Dir | F - Tax | $25.70 | -54.3K | 518.4K | -9% | -$1.39M | |
| 2026-09-03 16:16 | 2026-09-02 | BAX | Foster Julie | Pres, Front Line Care | F - Tax | $25.70 | -2,098 | 29.2K | -7% | -$53.9K | |
| 2026-06-03 16:07 | 2026-06-01 | BAX | Zielinski Anita A | SVP, CAO, Interim CFO, Cntrlr | A - Grant | $0.00 | +13.4K | 59.7K | +29% | $0 | |
| 2026-06-03 16:06 | 2026-06-02 | BAX | Wallace Steven P. | Pres, Adv. Surgery | F - Tax | $18.68 | -153 | 70.1K | -0.2% | -$2,858 | |
| 2026-06-03 16:05 | 2026-06-02 | BAX | Teaff James | Pres, CCS | F - Tax | $18.68 | -321 | 31.1K | -1% | -$5,996 | |
| 2026-05-07 16:22 | 2026-05-05 | BAX | Wilkes David S. | Dir | A - Grant | $0.00 | +12.8K | 37.1K | +53% | $0 | |
| 2026-05-07 16:21 | 2026-05-05 | BAX | Wendell Amy McBride | Dir | A - Grant | $0.00 | +12.8K | 44.2K | +41% | $0 | |
| 2026-05-07 16:20 | 2026-05-05 | BAX | SCHLICHTING NANCY M | Dir | A - Grant | $0.00 | +12.8K | 35.0K | +58% | $0 | |
| 2026-05-07 16:19 | 2026-05-05 | BAX | MORRISON PATRICIA | Dir | A - Grant | $0.00 | +12.8K | 42.4K | +43% | $0 | |
| 2026-05-07 16:19 | 2026-05-05 | BAX | Shafer David Brent | Dir, COB of the Board | A - Grant | $0.00 | +12.8K | 72.8K | +21% | $0 | |
| 2026-05-07 16:14 | 2026-05-05 | BAX | McDonnell Michael R. | Dir | A - Grant | $0.00 | +12.8K | 14.6K | +709% | $0 | |
| 2026-05-07 16:13 | 2026-05-05 | BAX | Craig Jeffrey A | Dir | A - Grant | $0.00 | +12.8K | 23.7K | +119% | $0 | |
| 2026-05-07 16:11 | 2026-05-05 | BAX | Ampofo William A. II | Dir | A - Grant | $0.00 | +12.8K | 30.4K | +73% | $0 | |
| 2026-03-10 | 2026-03-06 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $17.69 | -6,620 | 138.2K | -5% | -$117.1K | |
| 2026-03-10 | 2026-03-06 | BAX | Soriano Maria Cecilia | Group Pres, ITT, Pharma | F - Tax | $17.69 | -2,848 | 75.0K | -4% | -$50.4K | |
| 2026-03-10 | 2026-03-06 | BAX | Zielinski Anita A | SVP, CAO, Ctrl | F - Tax | $17.69 | -1,932 | 46.3K | -4% | -$34.2K | |
| 2026-03-10 | 2026-03-06 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | F - Tax | $17.69 | -12.7K | 125.6K | -9% | -$224.2K | |
| 2026-03-10 | 2026-03-06 | BAX | Grade Joel T. | EVP, CFO | F - Tax | $17.69 | -8,153 | 271.7K | -3% | -$144.2K | |
| DM | 2026-03-03 | 2026-02-27 | BAX | Carlisle Cynthia | EVP, CHRO | A - Grant | $0.00 | +29.7K | 29.7K | New | $0 |
| 2026-03-03 | 2026-03-02 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | F - Tax | $19.69 | -1,614 | 138.2K | -1% | -$31.8K | |
| D | 2026-03-03 | 2026-02-27 | BAX | Soriano Maria Cecilia | Group Pres, ITT, Pharma | A - Grant | $0.00 | +23.7K | 79.7K | +42% | $0 |
| D | 2026-03-03 | 2026-03-02 | BAX | Soriano Maria Cecilia | Group Pres, ITT, Pharma | F - Tax | $19.69 | -1,852 | 77.9K | -2% | -$36.5K |
| D | 2026-03-03 | 2026-02-27 | BAX | Grade Joel T. | EVP, CFO | A - Grant | $0.00 | +42.7K | 279.8K | +18% | $0 |
| D | 2026-03-03 | 2026-02-27 | BAX | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +26.7K | 146.2K | +22% | $0 |
| D | 2026-03-03 | 2026-03-02 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $19.69 | -1,336 | 144.8K | -0.9% | -$26.3K |
| 2026-03-03 | 2026-02-27 | BAX | Zielinski Anita A | SVP, CAO, Ctrl | A - Grant | $0.00 | +30.9K | 48.2K | +178% | $0 | |
| D | 2026-03-03 | 2026-02-27 | BAX | Hider Andrew P. | Pres, CEO, Dir | A - Grant | $0.00 | +201.8K | 572.2K | +54% | $0 |
| 2026-02-18 | 2026-02-13 | BAX | McDonnell Michael R. | Dir | A - Grant | $0.00 | +1,811 | 1,811 | New | $0 | |
| 2026-02-11 | 2026-02-09 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | A - Grant | $0.00 | +19.0K | 145.6K | +15% | $0 | |
| 2026-02-11 | 2026-02-09 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | F - Tax | $21.73 | -5,770 | 139.8K | -4% | -$125.4K | |
| 2026-02-11 | 2026-02-09 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $21.73 | -5,225 | 119.5K | -4% | -$113.5K | |
| 2026-02-11 | 2026-02-09 | BAX | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +17.1K | 124.7K | +16% | $0 | |
| 2026-02-11 | 2026-02-09 | BAX | Soriano Maria Cecilia | Group Pres, ITT, Pharma | A - Grant | $0.00 | +2,273 | 56.9K | +4% | $0 | |
| 2026-02-11 | 2026-02-09 | BAX | Soriano Maria Cecilia | Group Pres, ITT, Pharma | F - Tax | $21.73 | -918 | 56.0K | -2% | -$19.9K | |
| 2026-02-11 | 2026-02-09 | BAX | Grade Joel T. | EVP, CFO | F - Tax | $21.73 | -9,144 | 236.9K | -4% | -$198.7K | |
| 2026-02-11 | 2026-02-09 | BAX | Grade Joel T. | EVP, CFO | A - Grant | $0.00 | +30.5K | 246.0K | +14% | $0 | |
| 2025-12-16 | 2025-12-12 | BAX | Mason Jeanne K | EVP, Chief HR Off | F - Tax | $19.15 | -650 | 199.9K | -0.3% | -$12.4K | |
| 2025-12-03 | 2025-12-01 | BAX | Grade Joel T. | EVP, CFO | F - Tax | $19.08 | -8,288 | 215.2K | -4% | -$158.1K | |
| DM | 2025-09-04 | 2025-09-02 | BAX | Hider Andrew P. | Pres, CEO, Dir | A - Grant | $0.00 | +368.1K | 368.1K | New | $0 |
| 2025-09-04 | 2025-09-02 | BAX | Grade Joel T. | EVP, CFO | A - Grant | $0.00 | +102.7K | 222.6K | +86% | $0 | |
| 2025-09-04 | 2025-09-02 | BAX | Borzi James W | EVP, Chief Supply Chain Off | F - Tax | $24.17 | -1,848 | 71.9K | -3% | -$44.7K | |
| 2025-09-04 | 2025-09-02 | BAX | Sonig Alok | EVP, Group Pres, Pharma | F - Tax | $24.17 | -3,191 | 128.2K | -2% | -$77.1K | |
| 2025-08-21 | 2025-08-19 | BAX | Shafer David Brent | Dir, COB of the Board | F - Tax | $24.33 | -31.3K | 59.4K | -35% | -$762.4K | |
| 2025-06-04 | 2025-06-02 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $29.55 | -16.5K | 106.3K | -13% | -$489.0K | |
| 2025-05-08 | 2025-05-06 | BAX | Craig Jeffrey A | Dir | A - Grant | $0.00 | +7,183 | 10.7K | +206% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | SCHLICHTING NANCY M | Dir | A - Grant | $0.00 | +7,183 | 21.9K | +49% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | MORRISON PATRICIA | Dir | A - Grant | $0.00 | +7,183 | 29.1K | +33% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | RUSCKOWSKI STEPHEN H | Dir | A - Grant | $0.00 | +7,183 | 16.5K | +77% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | Oesterle Stephen N. | Dir | A - Grant | $0.00 | +7,183 | 35.8K | +25% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | Wilkes David S. | Dir | A - Grant | $0.00 | +7,183 | 23.9K | +43% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | Wendell Amy McBride | Dir | A - Grant | $0.00 | +7,183 | 31.2K | +30% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | Smith Cathy R | Dir | A - Grant | $0.00 | +7,183 | 30.3K | +31% | $0 | |
| 2025-05-08 | 2025-05-06 | BAX | Ampofo William A. II | Dir | A - Grant | $0.00 | +7,183 | 17.3K | +71% | $0 | |
| D | 2025-03-10 | 2025-03-06 | BAX | Borzi James W | EVP, Chief Supply Chain Off | F - Tax | $35.44 | -3,262 | 63.1K | -5% | -$115.6K |
| D | 2025-03-10 | 2025-03-06 | BAX | Borzi James W | EVP, Chief Supply Chain Off | A - Grant | $0.00 | +9,989 | 73.1K | +16% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | A - Grant | $0.00 | +26.2K | 124.6K | +27% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | F - Tax | $35.44 | -9,341 | 98.4K | -9% | -$331.0K |
| D | 2025-03-10 | 2025-03-06 | BAX | Grade Joel T. | EVP, CFO | F - Tax | $35.44 | -4,306 | 88.9K | -5% | -$152.6K |
| D | 2025-03-10 | 2025-03-06 | BAX | Grade Joel T. | EVP, CFO | A - Grant | $0.00 | +29.5K | 118.4K | +33% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Mason Jeanne K | EVP, Chief HR Off | A - Grant | $0.00 | +15.7K | 199.7K | +9% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Mason Jeanne K | EVP, Chief HR Off | F - Tax | $35.44 | -4,375 | 184.0K | -2% | -$155.1K |
| 2025-03-10 | 2025-03-06 | BAX | Zielinski Anita A | SVP, CAO, Ctrl | A - Grant | $0.00 | +17.1K | 17.1K | New | $0 | |
| D | 2025-03-10 | 2025-03-06 | BAX | Knight Heather | EVP, COO | F - Tax | $35.44 | -13.6K | 141.7K | -9% | -$483.2K |
| D | 2025-03-10 | 2025-03-06 | BAX | Knight Heather | EVP, COO | A - Grant | $0.00 | +35.7K | 177.4K | +25% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Sonig Alok | EVP, Group Pres, Pharma | F - Tax | $35.44 | -10.8K | 100.3K | -10% | -$384.1K |
| D | 2025-03-10 | 2025-03-06 | BAX | Sonig Alok | EVP, Group Pres, Pharma | A - Grant | $0.00 | +30.0K | 130.3K | +30% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +17.7K | 122.4K | +17% | $0 |
| D | 2025-03-10 | 2025-03-06 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $35.44 | -4,922 | 104.8K | -4% | -$174.4K |
| 2025-03-05 | 2025-03-03 | BAX | Sonig Alok | EVP, Group Pres, Pharma | F - Tax | $34.86 | -1,936 | 111.2K | -2% | -$67.5K | |
| 2025-03-05 | 2025-03-03 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $34.86 | -1,312 | 109.7K | -1% | -$45.7K | |
| 2025-03-05 | 2025-03-03 | BAX | Mason Jeanne K | EVP, Chief HR Off | F - Tax | $34.86 | -1,479 | 188.3K | -0.8% | -$51.6K | |
| 2025-03-05 | 2025-03-03 | BAX | Borzi James W | EVP, Chief Suppy Chain Off | F - Tax | $34.86 | -1,339 | 66.4K | -2% | -$46.7K | |
| 2025-03-05 | 2025-03-03 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | F - Tax | $34.86 | -1,987 | 107.7K | -2% | -$69.3K | |
| 2025-03-05 | 2025-03-03 | BAX | Knight Heather | EVP, COO | F - Tax | $34.86 | -3,344 | 155.3K | -2% | -$116.6K | |
| 2025-02-06 | 2025-02-05 | BAX | Shafer David Brent | COB, Interim CEO, Dir | A - Grant | $0.00 | +76.3K | 89.8K | +563% | $0 | |
| 2025-02-04 | 2025-01-31 | BAX | Toth Christopher A. | EVP, Group Pres, Kidney Care | F - Tax | $32.56 | -25.4K | 105.2K | -19% | -$826.1K | |
| 2025-01-03 | 2024-12-31 | BAX | Toth Christopher A. | EVP, Group Pres, Kidney Care | F - Tax | $29.16 | -32.6K | 183.9K | -15% | -$950.9K | |
| 2024-12-17 | 2024-12-13 | BAX | ALMEIDA JOSE E | COB, CEO, Pres | F - Tax | $30.32 | -5,966 | 243.6K | -2% | -$180.9K | |
| 2024-12-04 | 2024-12-02 | BAX | Knight Heather | EVP, Group Pres, Med Products | F - Tax | $33.55 | -6,041 | 157.7K | -4% | -$202.7K | |
| 2024-12-04 | 2024-12-02 | BAX | Grade Joel T. | EVP, CFO | F - Tax | $33.55 | -6,612 | 92.5K | -7% | -$221.8K | |
| 2024-12-04 | 2024-12-02 | BAX | Rasul Reazur | EVP, Group Pres, Healthcare | F - Tax | $33.55 | -2,032 | 109.1K | -2% | -$68.2K | |
| 2024-09-11 | 2024-09-09 | BAX | Craig Jeffrey A | Dir | A - Grant | $0.00 | +3,472 | 3,472 | New | $0 | |
| 2024-09-05 | 2024-09-03 | BAX | Sonig Alok | EVP, Group Pres, Pharma | F - Tax | $37.85 | -3,054 | 111.6K | -3% | -$115.6K | |
| 2024-09-05 | 2024-09-03 | BAX | Borzi James W | EVP, Chief Supply Chain Off | F - Tax | $37.85 | -1,685 | 66.9K | -2% | -$63.8K | |
| 2024-06-05 | 2024-06-03 | BAX | Rosenbloom David S. | EVP, GC | F - Tax | $34.08 | -784 | 108.6K | -0.7% | -$26.7K | |
| 2024-06-05 | 2024-06-03 | BAX | Toth Christopher A. | EVP, Group Pres, Kidney Care | F - Tax | $34.08 | -15.2K | 213.3K | -7% | -$518.1K | |
| 2024-05-09 | 2024-05-07 | BAX | Smith Cathy R | Dir | A - Grant | $0.00 | +5,952 | 22.5K | +36% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | SCHLICHTING NANCY M | Dir | A - Grant | $0.00 | +5,952 | 14.3K | +71% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | RUSCKOWSKI STEPHEN H | Dir | A - Grant | $0.00 | +5,952 | 9,068 | +191% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | Wilkes David S. | Dir | A - Grant | $0.00 | +5,952 | 16.3K | +58% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | Oesterle Stephen N. | Dir | A - Grant | $0.00 | +5,952 | 27.9K | +27% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | Wendell Amy McBride | Dir | A - Grant | $0.00 | +5,952 | 23.9K | +33% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | WILVER PETER M | Dir | A - Grant | $0.00 | +5,952 | 13.3K | +81% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | Shafer David Brent | Dir | A - Grant | $0.00 | +5,952 | 13.3K | +81% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | MORRISON PATRICIA | Dir | A - Grant | $0.00 | +5,952 | 21.4K | +39% | $0 | |
| 2024-05-09 | 2024-05-07 | BAX | Ampofo William A. II | Dir | A - Grant | $0.00 | +5,952 | 9,847 | +153% | $0 | |
| 2024-03-08 | 2024-03-06 | BAX | Rosenbloom David S. | EVP, GC | A - Grant | $0.00 | +53.6K | 109.0K | +97% | $0 | |
| 2024-03-08 | 2024-03-06 | BAX | Toth Christopher A. | EVP, Group Pres, Kidney Care | A - Grant | $0.00 | +119.1K | 227.8K | +110% | $0 | |
| 2024-03-08 | 2024-03-06 | BAX | Sonig Alok | EVP, Group Pres, Pharma | A - Grant | $0.00 | +83.4K | 113.5K | +277% | $0 |
Purchase Sale Sale after option exercise All abbreviations